-
1 Comment
Shandong Jintai Group Co., Ltd is currently in a long term uptrend where the price is trading 21.9% above its 200 day moving average.
From a valuation standpoint, the stock is 15.3% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 11.1.
Shandong Jintai Group Co., Ltd's total revenue rose by 1371.3% to $15M since the same quarter in the previous year.
Its net income has increased by 118.6% to $488K since the same quarter in the previous year.
Finally, its free cash flow grew by 799.4% to $8M since the same quarter in the previous year.
Based on the above factors, Shandong Jintai Group Co., Ltd gets an overall score of 4/5.
| Sector | Consumer Discretionary |
|---|---|
| Industry | Textiles, Apparel &Â Luxury Goods |
| Exchange | SHG |
| CurrencyCode | CNY |
| ISIN | CNE0000018K3 |
| Market Cap | 178M |
|---|---|
| Beta | 0.14 |
| Dividend Yield | 0.0% |
| PE Ratio | 40.0 |
| Target Price | None |
Shandong Jintai Group Co., Ltd. produces and distributes chemical reagent medicines in China. The company provides tablets, capsules, ointments, membranes, and others. It is also involved in the enterprise investment business, as well as in the provision of leasing services. The company is based in Jinan, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600385.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
